Average bioequivalence for two-sequence two-period crossover design with incomplete data

Journal of Biopharmaceutical Statistics

Volumn 15, Issue 5, 2005, Pages 857-867

  Lee, Jae Young ^a   Kim, Byung Chun ^a   Park, Sang Gue ^b  

^a Korea Advanced Institute of Science and Technology Business School   (South Korea)

^b Chung Ang University   (South Korea)

Author keywords

Average bioequivalence; Incomplete crossover design; Maximum likelihood estimation; Missing at random

Indexed keywords

UNCLASSIFIED DRUG;

BIOEQUIVALENCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DATA ANALYSIS; HUMAN; MAXIMUM LIKELIHOOD METHOD; MONTE CARLO METHOD; PRIORITY JOURNAL; RANDOMIZATION; REVIEW; SIMULATION; STATISTICAL ANALYSIS;

CROSS-OVER STUDIES; DRUG THERAPY; MODELS, STATISTICAL; MONTE CARLO METHOD; RANDOMIZED CONTROLLED TRIALS; THERAPEUTIC EQUIVALENCY;

EID: 22544457594     PISSN: 10543406     EISSN: 15205711     Source Type: Journal    
DOI: 10.1081/BIP-200067986     Document Type: Review

References (14)

1. Chow, S. C., Liu, J. P. (2000). Design and Analysis of Bioavailability and Bioequivalence Studies. New York: Marcel Dekker.
2. Chow, S. C., Shao, J. (1997). Statistical methods for two-sequence three-period cross-over designs with incomplete data. Stat. Med. 16:1031-1039.
3. Dahiya, R. C., Korwar, R. M. (1980). Maximum likelihood estimates for a bivariate normal distribution with missing data. Annals Stat. 8:687-692.
4. Johnson, N. L., Kotz, S. (1972). Distributions in Statistics: Continuous Multivariate Distributions. New York: Wiley.
5. Kenward, M. G., Molenberghs, G. (1998). Likelihood based frequentist inference when data are missing at random. Stat. Sci. 13:236-247.
6. Korea Food and Drug Administration. (2002). KFDA Publications 2002-61.
7. Littell, R. C., Milliken, G. A., Stroup, W. W., Wolfinger, R. D. (1996). SAS System for Mixed Models. Cary, NC: SAS Institute. Inc.
8. Little, R. J., Rubin, D. B. (2002). Statistical Analysis with Missing Data. New York: Wiley.
9. Morrison, D. F. (1973). A test for equality of means of correlated variates with missing data on one response. Biometrika 60:101-105.
10. Patel, H. I. (1985). Analysis of incomplete data in a two-period crossover design with reference to clinical trials. Biometrika 72:411-418.
11. Patel, H. I. (1991). Analysis of incomplete data from a clinical trial with repeated measurements. Biometrika 78:609-619.
12. Rani, S., Pargal, A. (2004). Bioequivalence: An overview of statistical concepts. Indian J. Pharm. 36:209-216.
13. Schuirmann, D. J. (1987). A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. J. Pharm. and Biopharm. 15:657-680.
14. U.S. Food and Drug Administration. (1992). Guidance on statistical procedures for bioequivalence using a standard two-treatment crossover design. Division of Bioequivalence, Office of Generic Drugs, Center for Drug Evaluation and Research.